Baird Reiterates Outperform on Zimmer Biomet Holdings, Maintains $172 Price Target
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Jeff Johnson has reiterated an Outperform rating on Zimmer Biomet Holdings (NYSE:ZBH) and maintained a price target of $172.
June 28, 2023 | 2:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Baird analyst Jeff Johnson has reiterated an Outperform rating on Zimmer Biomet Holdings and maintained a price target of $172.
The reiteration of an Outperform rating by Baird's Jeff Johnson indicates a positive outlook for Zimmer Biomet Holdings. The maintained price target of $172 suggests that the analyst believes the stock has potential for growth. This could positively impact the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100